Xiaofeng Chen
Impact in
- Cancer Research top 10%
- Cancer Genomics and Diagnostics
- Cancer-related molecular mechanisms research
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
Papers in
-
- Gastric Cancer Management and Outcomes 13
- Lung Cancer Treatments and Mutations 9
- Oncology 26
- Colorectal Cancer Treatments and Studies 5
- Peptidase Inhibition and Analysis 5
- Cancer Immunotherapy and Biomarkers 4
- Co-authors
- Yongmei Yin (9 shared papers)Yongqian Shu (20 shared papers)Yiqian Liu (8 shared papers)Yanhong Gu (18 shared papers)Yongqian Shu (3 shared papers)Oluf Dimitri Røe (8 shared papers)Jinrong Qiu (7 shared papers)Lingjun Zhu (4 shared papers)
- Journals
- Journal of Clinical Oncology (11 papers)Biomedicine & Pharmacotherapy (4 papers)OncoTargets and Therapy (4 papers)PLoS ONE (3 papers)Medicine (3 papers)
- Partner nations
- ChinaUnited StatesNorway
In The Last Decade
Xiaofeng Chen
83 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 90
- Cancer Research 247
- Oncology 374
- Toxicology 42
- Pulmonary and Respiratory Medicine 305
- Pathology and Forensic Medicine 87
Countries citing papers authored by Xiaofeng Chen
This map shows the geographic impact of Xiaofeng Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaofeng Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaofeng Chen more than expected).
Fields of papers citing papers by Xiaofeng Chen
This network shows the impact of papers produced by Xiaofeng Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaofeng Chen. The network helps show where Xiaofeng Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaofeng Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 87 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 147 | |
| 2 | 2020 | 61 | |
| 3 | 2023 | 59 | |
| 4 | 2013 | 51 | |
| 5 | 2020 | 51 | |
| 6 | 2013 | 50 | |
| 7 | 2009 | 44 | |
| 8 | 2019 | 43 | |
| 9 | 2018 | 41 | |
| 10 | 2013 | 40 | |
| 11 | 2012 | 40 | |
| 12 | 2019 | 37 | |
| 13 | 2022 | 34 | |
| 14 | 2014 | 28 | |
| 15 | 2014 | 26 | |
| 16 | 2019 | 24 | |
| 17 | 2013 | 20 | |
| 18 | 2015 | 20 | |
| 19 | 2015 | 19 | |
| 20 | 2015 | 19 |
About Xiaofeng Chen
Xiaofeng Chen is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Surgery, Molecular Biology and Pathology and Forensic Medicine, having authored 87 papers that have together received 1.2k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (13 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (10 papers), Lung Cancer Treatments and Mutations (9 papers), Terahertz technology and applications (6 papers), Colorectal Cancer Treatments and Studies (5 papers), Peptidase Inhibition and Analysis (5 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Esophageal Cancer Research and Treatment (4 papers). The work is most often cited by research in Cancer Research (247 citations), Oncology (374 citations), Toxicology (42 citations), Pulmonary and Respiratory Medicine (305 citations) and Pathology and Forensic Medicine (87 citations). Xiaofeng Chen has collaborated with scholars based in China, United States and Norway. Frequent co-authors include Yongmei Yin, Yongqian Shu, Yiqian Liu, Yanhong Gu, Yongqian Shu, Oluf Dimitri Røe, Jinrong Qiu, Lingjun Zhu, Yang Shao and Tianzhu Qiu. Their work appears in journals such as Journal of Clinical Oncology, Biomedicine & Pharmacotherapy, OncoTargets and Therapy, PLoS ONE and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.